• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有晚霞状眼底的Vogt-小柳-原田病的免疫组织化学研究

Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.

作者信息

Inomata H, Sakamoto T

机构信息

Department of Ophthalmology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Curr Eye Res. 1990;9 Suppl:35-40. doi: 10.3109/02713689008999417.

DOI:10.3109/02713689008999417
PMID:1974489
Abstract

We studied Vogt-Koyanagi-Harada disease (VKH) with sunset sky fundus using histopathology and immunohistochemical methods. The materials examined were 4 eyes obtained at autopsy on two patients with VKH. The first patient died 32 months after the onset of VKH, and the other 7 years after onset. Histopathology of the eyes showed scattering infiltration of lymphocytes in the thickened choroid with a remarkable disappearance of choroidal melanocytes. T and B lymphocytes were identified by immunohistochemistry, using monoclonal antibodies. Approximately 70% of the lymphocytes were T cells. In the case 1 patient, the ratio of CD4+ to CD8+ T cells was 2 to 3. Thus, the evidence of T and B lymphocytes in these uveal tissues indicates that the inflammation remained active even at the convalescent stage.

摘要

我们采用组织病理学和免疫组化方法研究了伴有晚霞状眼底的伏格特-小柳-原田病(VKH)。所检查的材料为两名VKH患者尸检时获取的4只眼睛。第一名患者在VKH发病32个月后死亡,另一名在发病7年后死亡。眼部组织病理学显示,增厚的脉络膜中有淋巴细胞散在浸润,脉络膜黑素细胞明显消失。使用单克隆抗体通过免疫组化鉴定出T淋巴细胞和B淋巴细胞。约70%的淋巴细胞为T细胞。在病例1患者中,CD4 + T细胞与CD8 + T细胞的比例为2比3。因此,这些葡萄膜组织中存在T淋巴细胞和B淋巴细胞的证据表明,即使在恢复期炎症仍处于活跃状态。

相似文献

1
Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.伴有晚霞状眼底的Vogt-小柳-原田病的免疫组织化学研究
Curr Eye Res. 1990;9 Suppl:35-40. doi: 10.3109/02713689008999417.
2
Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.
Arch Ophthalmol. 1991 Sep;109(9):1270-4. doi: 10.1001/archopht.1991.01080090096030.
3
Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.Vogt-小柳-原田病中的白癜风:炎症部位的免疫组织学分析
Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):359-63. doi: 10.1007/BF00190711.
4
Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病晚霞样眼底的色素脱失萎缩性病变。
Am J Ophthalmol. 2001 May;131(5):607-14. doi: 10.1016/s0002-9394(00)00851-5.
5
Choroidal neovascularization in long-standing case of Vogt-Koyanagi-Harada disease.伏格特-小柳-原田病长期病例中的脉络膜新生血管形成
Jpn J Ophthalmol. 1983;27(1):9-26.
6
Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.伏格特-小柳-原田病伴或不伴慢性眼部炎症时的晚霞状眼底。
Graefes Arch Clin Exp Ophthalmol. 2002 Oct;240(10):878-82. doi: 10.1007/s00417-002-0538-z. Epub 2002 Sep 6.
7
Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.从Vogt-小柳-原田病患者脑脊液中分离出的T细胞无法识别常见黑素细胞抗原。
Mol Vis. 2014 Jul 2;20:956-69. eCollection 2014.
8
Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.与Vogt-小柳-原田综合征活动性葡萄膜炎相关的CD4+CD25高调节性T细胞频率和功能降低。
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3475-82. doi: 10.1167/iovs.08-1793. Epub 2008 Apr 17.
9
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.霉酚酸酯联合全身用糖皮质激素可预防与Vogt-小柳-原田病相关的初发性急性葡萄膜炎进展为慢性复发性炎症和“晚霞眼底”的形成。
Acta Ophthalmol. 2017 Feb;95(1):85-90. doi: 10.1111/aos.13189. Epub 2016 Aug 18.
10
Choroidal thickness in convalescent vogt-koyanagi-harada disease.恢复期 Vogt-小柳-原田病的脉络膜厚度。
Retina. 2014 Apr;34(4):775-80. doi: 10.1097/IAE.0b013e3182a6b3f6.

引用本文的文献

1
Safety and efficacy of rituximab in refractory noninfectious uveitis and scleritis.利妥昔单抗治疗难治性非感染性葡萄膜炎和巩膜炎的安全性与有效性。
J Ophthalmic Inflamm Infect. 2025 Sep 26;15(1):70. doi: 10.1186/s12348-025-00522-5.
2
Uveodermatological syndrome in dogs: A review of diagnosis, management, and ophthalmic patient needs.犬葡萄膜皮肤综合征:诊断、治疗及眼科患者需求综述
Vet Med (Praha). 2025 Jun 25;70(6):185-195. doi: 10.17221/10/2025-VETMED. eCollection 2025 Jun.
3
Retrospective analysis of Vogt-Koyanagi-Harada's recurrence within a case series of nineteen patients followed between 2003 and 2018 in an academic center.
对19例患者在2003年至2018年期间于某学术中心进行随访的病例系列中Vogt-小柳-原田病复发情况的回顾性分析。
J Ophthalmic Inflamm Infect. 2025 Jul 1;15(1):50. doi: 10.1186/s12348-025-00498-2.
4
Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.预测因素与阿达木单抗治疗慢性复发性 Vogt-Koyanagi-Harada 病的疗效。
BMC Ophthalmol. 2024 Jun 7;24(1):238. doi: 10.1186/s12886-024-03511-9.
5
Vogt-Koyanagi-Harada Disease: A Narrative Review.伏格特-小柳-原田病:一篇叙述性综述
Cureus. 2024 Apr 23;16(4):e58867. doi: 10.7759/cureus.58867. eCollection 2024 Apr.
6
Classification of Peripheral Blood Leukocyte Phenotypes and Serum Cytokines in Vogt-Koyanagi-Harada Disease before and after Glucocorticoid Therapy.糖皮质激素治疗前后葡萄膜炎-白癜风-脱发-耳鸣综合征患者外周血白细胞表型及血清细胞因子的分类
J Clin Med. 2023 Dec 17;12(24):7742. doi: 10.3390/jcm12247742.
7
Vogt-Koyanagi-Harada disease in a patient with extreme anisometropia.患有极度屈光参差的患者的伏格特-小柳-原田病。
Am J Ophthalmol Case Rep. 2023 Sep 21;32:101929. doi: 10.1016/j.ajoc.2023.101929. eCollection 2023 Dec.
8
Association of Retinal Pigment Epithelium Reflectivity on Optical Coherence Tomography with Recurrence of Vogt-Koyanagi-Harada Disease: A Retrospective Observational Study.光学相干断层扫描中视网膜色素上皮反射率与Vogt-小柳-原田病复发的相关性:一项回顾性观察研究
Clin Ophthalmol. 2023 Jul 21;17:2071-2079. doi: 10.2147/OPTH.S419546. eCollection 2023.
9
Hyperfluorescence of choroidal arteries in the peripheral fundus on late-phase ICGA.脉络膜动脉在晚期吲哚青绿血管造影时周边眼底高荧光。
Eye (Lond). 2023 Nov;37(16):3502-3505. doi: 10.1038/s41433-023-02545-5. Epub 2023 May 8.
10
Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.病例报告:第二剂 BNT162b2 mRNA COVID-19 疫苗接种后双侧全葡萄膜炎,类似 Vogt-Koyanagi-Harada 病。
Front Immunol. 2022 Sep 29;13:967972. doi: 10.3389/fimmu.2022.967972. eCollection 2022.